Global Buprenorphine Hydrochloride Market Size By Product Type, By Indication, By Distribution Channel, By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Buprenorphine Hydrochloride Market Size By Product Type, By Indication, By Distribution Channel, By Geographic Scope And Forecast
Buprenorphine Hydrochloride Market Size And Forecast
The global Buprenorphine Hydrochloride Market size is valued at USD 135.67 Million in 2023 and is projected to reach USD 178.09 Million by 2030, growing at a CAGR of 4.62% during the forecast period 2024-2030.
Global Buprenorphine Hydrochloride Market Drivers
The market drivers for the Buprenorphine Hydrochloride Market can be influenced by various factors. These may include
Government Initiatives Many nations’ governments and healthcare institutions have realised the need of addressing the opioid issue. In order to enhance access to buprenorphine-based treatment, they have created policies and programmes, which has fueled market expansion.
Rising Substance Abuse Rates In some areas, the use of opioids has been on the rise, which has increased the need for treatments based on buprenorphine.
Effectiveness and Safety Buprenorphine is thought to be safe and effective at treating opioid addiction compared to full opioid agonists. It is a desirable therapy option due to its safety profile.
Growing Awareness Buprenorphine prescription and use have increased as a result of greater patient and healthcare professional understanding of the benefits of the drug in treating opiate addiction.
Expanded Indications Buprenorphine has uses besides the treatment of addiction, such as the control of chronic pain. The market for buprenorphine hydrochloride is becoming more varied as its applications grow.
Patient-Centered Care The use of drugs like buprenorphine as part of a thorough treatment programme has been motivated by a change towards patient-centered care and a focus on addressing the causes of addiction.
Market competition has fueled innovation and market expansion by driving pharmaceutical companies to create and sell various buprenorphine hydrochloride formulations and delivery systems.
Insurance Coverage Buprenorphine-based treatments are now more widely available due to improved insurance coverage and payment guidelines.
Telemedicine and telehealth The availability of buprenorphine treatment and monitoring has expanded as a result of the development of telemedicine and telehealth services, particularly during the COVID-19 pandemic.
Research and Development Ongoing initiatives to enhance the formulation, distribution, and efficacy of buprenorphine products contribute to the expansion of the market.
Global Market Expansion As opioid addiction becomes a global issue, the buprenorphine market has been expanding outside of North America to places like Europe and Asia.
Patient Preference Due to buprenorphine’s partial agonist qualities, which can lead to less euphoria and less withdrawal symptoms than full opioid agonists, some patients prefer buprenorphine-based therapy.
Global Buprenorphine Hydrochloride Market Restraints
Several factors can act as restraints or challenges for the Buprenorphine Hydrochloride Market. These may include
Regulation Obstacles Production, distribution, and prescription of drugs based on buprenorphine can be restricted by strict guidelines and oversight by health authorities. Compliance with regulations can be difficult and expensive.
Treatment for addiction is stigmatised Buprenorphine is underused because of the stigma attached to addiction and opioid use disorder, which deters people from seeking treatment.
Limitations on prescribing Access to care may be hampered by constraints on some healthcare practitioners’ ability to prescribe buprenorphine, such as caps on the number of patients they can treat.
Accessibility and price Some patients may find the expense of buprenorphine prescriptions and related treatment services to be a barrier, especially those who lack sufficient insurance or financial resources.
Capacity for Treating Opioid Agonists Long wait times and restricted access to treatment using buprenorphine might occur in areas where opioid agonist therapy (OAT) programmes or clinics are not readily available.
Misuse and diversion Buprenorphine availability and prescription procedures may be affected by worries about diversion (illegal distribution) and overuse, which may result in tougher controls.
Market competition Pricing pressures brought on by competition among pharmaceutical companies that make drugs based on buprenorphine may have an impact on profit margins.
Alternative Medicine The market share of medications based on buprenorphine may be impacted by the availability of alternative addiction treatment options like methadone or naltrexone.
Adherence to Treatment and Relapse In addiction therapy, maintaining patient adherence to buprenorphine treatment regimens and avoiding relapse are constant issues.
Infrastructure for health care The availability of buprenorphine-based treatment may be constrained in some areas due to a lack of healthcare infrastructure that can support comprehensive addiction treatment programmes.
Public Education and Awareness Adoption of buprenorphine may be hampered by a lack of knowledge and education among medical professionals and the general public regarding its advantages in the treatment of addiction.
Payment Guidelines The cost and accessibility of buprenorphine-based treatment may be impacted by reimbursement guidelines set by insurance companies and public health initiatives.
Illegal and Counterfeit Markets The availability of illegal or fake buprenorphine products in particular marketplaces might endanger consumers’ health and undermine their faith in safe, effective pharmaceuticals.
Concerns about dependence and withdrawal Since buprenorphine is an opioid in and of itself, some people might develop reliant on it. Some patients may be discouraged from getting therapy due to worries about buprenorphine withdrawal.
Global Buprenorphine Hydrochloride Market Segmentation Analysis
The Global Buprenorphine Hydrochloride Market is segmented on the basis of Product Type, Indication, Distribution Channel, and Geography.
Buprenorphine Hydrochloride Market, By Product Type
Buprenorphine Monotherapy This includes buprenorphine formulations that contain buprenorphine as the sole active ingredient, typically used for opioid addiction treatment.
Combination Products Buprenorphine combined with naloxone to deter misuse and diversion. This combination is often used in addiction treatment.
Buprenorphine Hydrochloride Market, By Indication
Opioid Use Disorder (OUD) Treatment Buprenorphine is primarily used for the treatment of OUD, and this segment focuses on medications used in opioid addiction treatment programs.
Chronic Pain Management Buprenorphine is also used to manage chronic pain, and this segment includes products designed for pain management.
Buprenorphine Hydrochloride Market, By Distribution Channel
Hospital Pharmacies Buprenorphine products dispensed through hospital-based pharmacies.
Retail Pharmacies Products available at retail pharmacies for prescription filling.
Online Pharmacies Buprenorphine may be available through online pharmacies where permitted by law and regulation.
Buprenorphine Hydrochloride Market, By Geography
North AmericaMarket conditions and demand in the United States, Canada, and Mexico.
EuropeAnalysis of the Buprenorphine Hydrochloride Market in European countries.
Asia-PacificFocusing on countries like China, India, Japan, South Korea, and others.
Middle East and AfricaExamining market dynamics in the Middle East and African regions.
Latin AmericaCovering market trends and developments in countries across Latin America.
Key Players
The major players in the global buprenorphine hydrochloride market include
Indivior
Reckitt Benckiser Group
Camurus
Hikma Pharmaceuticals
Mylan
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Wockhardt
Sandoz
Sun Pharmaceutical Industries
Cipla
Report Scope
REPORT ATTRIBUTES
DETAILS
Study Period
2020-2030
Base Year
2023
Forecast Period
2024-2030
Historical Period
2020-2022
Unit
Value (USD Million)
Key Companies Profiled
Indivior, Reckitt Benckiser Group, Camurus, Hikma Pharmaceuticals, Mylan, Teva Pharmaceutical Industries, Dr. Reddy’s Laboratories, Wockhardt, Sandoz, Sun Pharmaceutical Industries, Cipla
Segments Covered
By Product Type, By Indication, By Distribution Channel, and By Geography.
Customization scope
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.
Table of Content
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Buprenorphine Hydrochloride Market Size By Product Type, By Indication, By Distribution Channel, By Geographic Scope And Forecast
